Sept 17-19, 2019
Parsippany, New Jersey Hilton Hotel

> 2018 Exhibitors

> 2017 Exhibitors

> 2016 Exhibitors

Download 2019 Exhibitor Manual

Download Exhibitor Electric Form

ChemOutsourcing Banner To Alert Contacts You’re Attending

2019 Exhibitor List

read: buyers and suppliers together

Exhibitor List As Of July 18, 2019

Look for exhibitors according to their first letter.

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Show All

 

Dipharma/Kalexsyn
Dottikon
Dr Reddy's Laboratories

Dipharma/Kalexsyn, Booth 78

Kalexsyn’s world-class scientists provide hit validation, lead optimization and solving tough synthetic problems. We also provide stable label synthesis and custom synthesis. Our process route development, process improvement and early API team is comprised of a group of senior scientists formerly with large pharma API teams. We offer clients an outstanding CRO experience with fixed quote, tailored short and long term FTE arrangements. Kalexsyn is privately owned with research laboratories in

Dipharma Group is highlighted on the market as one of the major European players in the field of Bulk Active Pharmaceutical Ingredients having a portfolio of about 60 APIs, with DMFs filed worldwide. We serve top ranking pharmaceutical companies in Europe, U.S.A. and Japan, supported by a fully equipped R&D Centre, consisting of more than 40 qualified researchers.

Modern laboratory equipment and one dedicated pilot plant enable us to develop and optimize complex chemical synthetic processes. Our three plants, operating in full cGMP, with a total capacity of about 550 m3, have been regularly inspected by US FDA through the years. All above competencies and capabilities make Dipharma the right partner for Custom Synthesis.

Our core technologies are Nitration, Nitroesterification, Azide Chemistry, High Pressure Hydrogenations, Chiral Synthesis, Organometallic Chemistry and Enzymatic Processes.”

Dottikon, Booth 48

DOTTIKON EXCLUSIVE SYNTHESIS is specialized on hazardous chemistry, with a focus on strongly exothermic reactions as well as unstable, highly reactive, or high-potent compounds or mixtures. DOTTIKON ES manufactures high-quality intermediates and exclusive APIs, from the kilogram to the multi-ton range, for the world's leading pharmaceutical and chemical industries. Hazardous reactions often allow to shorten production and synthesic procedures, reduce waste, improve yields, selectivity, and purity, an

Dr Reddy's Laboratories, Booth 51 [ company website ]